Business Context and Reporting Period
This Form 8-K was filed by Organovo Holdings, Inc. on April 23, 2025. The report announces a corporate rebranding effective April 24, 2025. The company will carry forward its 3D bioprinting and legacy technology under the new name VivoSim Labs, Inc. The company's common stock will trade on the Nasdaq Capital Market under the new ticker symbol VIVS.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a name change and ticker symbol update and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name: Changed from Organovo Holdings, Inc. to VivoSim Labs, Inc.
- Trading Symbol: Changed from ONVO to VIVS.
- Effective Date: April 24, 2025.
Guidance, Outlook, and Risks
The filing indicates the company will continue its operations in 3D bioprinting and legacy technology under the new brand. No specific financial guidance, forward-looking projections, or new risk factors were disclosed in this document. The press release referenced in Item 7.01 is furnished but not deemed "filed" for liability purposes under Section 18 of the 1934 Act.
Key Facts for Investor Verification
- Verify the new ticker symbol VIVS on the Nasdaq Capital Market effective April 24, 2025.
- Confirm the legal name change to VivoSim Labs, Inc. in corporate registries.
- Review the attached press release (Exhibit 99.1) for any additional strategic details not included in the 8-K summary.